References
- Hannu T, Inman R, Granfors K, Leirisalo-Repo M. Reactive arthritis or post-infectious arthritis?. Best Pract Res Clin Rheumatol 2006; 20: 419–33
- Wilson JS, Honey E, Templeton A, Paavonen J, Mardh P-A, Stary A, et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Human Repr Update 2002; 8: 385–94
- Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Croh A, Uksila J, et al. Frequency of triggering bacteria in patients of reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used in diagnosis. Ann Rheum Dis 2001; 60: 337–43
- Butrimiene I, Ranceva J, Griskevicius A. Potential triggering infections of reactive arthritis. Scand J Rheumatol 2006; 35: 459–62
- Isomaki H, Raunio J, von Essen R, Hameenkorpi R. Incidence of inflammatory rheumatic diseases in Finland. Scand J Rheumatol 1978; 7: 188–92
- Kvien TK, Glennass A, Melby K, Granfors K, Andrup O, Karstensen B, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol 1994; 21: 115–22
- Savolainen E, Kaipiainen-Seppanen O, Kroger L, Luosujarvi R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 Arthritis Survey. J Rheumatol 2003; 30: 2460–8
- Koivisto AL, Isoaho R, Von Hertzen L, Toyryla M, Laippala P, Kivela SL, et al. Chlamydial antibodies in an elderly Finnish population. Scand J Infect Dis 1999; 31: 135–9
- Bas S, Scieux C, Vischer TL. Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?. Ann Rheum Dis 2001; 60: 605–11
- Bas S, Genevay S, Schenkel MC, Vischer TL. Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis. Rheumatology 2002; 41: 1017–20
- Nikkari S, Puolakkainen M, Narvanen A, Aakre O, Toivanen P, Leirisalo-Repo M. Use of a peptide-based enzyme immunoassay in diagnosis of Chlamydia trachomatis-triggered reactive arthritis. J Rheumatol 2001; 28: 2487–93
- Narvanen A, Puolakkainen M, Wu H, Kohsuke K, Suni J. Detection of antibodies to Chlamydia trachomatis with a peptide-based species-specific enzyme immunoassay. Inf Dis Obst Gyn 1997; 5: 349–5
- Lyytikainen E, Kaasila M, Koskela P, Lehtinen M, Patama T, Pukkala E, et al. Chlamydia trachomatis seroprevalence atlas of Finland 1983–2003. Sex Transm Infect 2008; 84: 19–22
- Lysen M, Osterlund A, Rubin CJ, Persson T, Persson I, Herrmann B. Characterization of ompA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish County. J Clin Microbiol 2004; 42: 1641–7
- Paukku M, Kilpikari R, Puolakkainen M, Oksanen H, Apter D, Paavonen J. Criteria for selective screening for Chlamydia trachomatis. Sex Transm Dis 2003; 30: 120–3